PIK3CB and ovarian carcinoma: To the best of our knowledge, we demonstrated for the first time that tyrosine kinase receptor TIE-1 participates in cell growth and proliferation by targeting the PI3K/Akt signaling pathway in high-PI3K-expressing ovarian cancer cells.